A Double-Blind, Randomized, Placebo-Controlled, Sequential, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Doses of VBY-036 in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 07 Jan 2014
At a glance
- Drugs VBY 036 (Primary)
- Indications Neuropathic pain
- Focus Adverse reactions
- Sponsors Virobay
- 07 Jan 2014 Status changed from recruiting to completed, as per ClinicalTrials.gov record.
- 15 Jul 2013 Planned end date added to 1 Nov 2013 as reported by ClinicalTrials.gov record.
- 10 Jul 2013 New source identified and integrated: ClinicalTrials.gov record.